Home
XERS
XERS News

Latest Xeris Biopharma Holdings Inc. (XERS) News on July 26, 2024

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Business Wire

2 days ago

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?

Zacks

2 days ago

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?

MT Newswires

18 days ago

Xeris Biopharma Appoints John Shannon as CEO

Xeris Biopharma Announces CEO Succession Plan

Business Wire

19 days ago

Xeris Biopharma Announces CEO Succession Plan

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

23 days ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit

Simply Wall St.

2 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

Business Wire

2 months ago

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

MT Newswires

2 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

2 months ago

Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Business Wire

2 months ago

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris to Participate in the Jefferies Global Healthcare Conference

Business Wire

2 months ago

Xeris to Participate in the Jefferies Global Healthcare Conference

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges

GuruFocus.com

3 months ago

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

3 months ago

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Xeris Biopharma Holdings Inc Earnings Call

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates

Zacks

3 months ago

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates

Associated Press Finance

3 months ago

Xeris Biopharma: Q1 Earnings Snapshot

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

Business Wire

3 months ago

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

MT Newswires

3 months ago

Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

ACCESSWIRE

3 months ago

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock

Simply Wall St.

3 months ago

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Business Wire

3 months ago

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

Zacks

3 months ago

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Simply Wall St.

4 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

4 months ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

4 months ago

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results

Simply Wall St.

5 months ago

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023

GuruFocus.com

5 months ago

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Xeris Biopharma Holdings Inc Earnings Call

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates

Zacks

5 months ago

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates

Associated Press Finance

5 months ago

Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Business Wire

5 months ago

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Business Wire

5 months ago

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Why Xeris (XERS) Might Surprise This Earnings Season

Zacks

5 months ago

Why Xeris (XERS) Might Surprise This Earnings Season

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Business Wire

5 months ago

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

Business Wire

6 months ago

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire

6 months ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root

PR Newswire

6 months ago

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies

Business Wire

6 months ago

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies

Investing.com

6 months ago

Dollar edges higher ahead of Fed meeting, payrolls

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14

GlobeNewswire

6 months ago

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14

Thomson Reuters StreetEvents

6 months ago

Q4 2023 CrossFirst Bankshares Inc Earnings Call

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

6 months ago

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024

GlobeNewswire

6 months ago

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics

Zacks

6 months ago

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

6 months ago

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza

Zacks

6 months ago

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza

The RMR Group Announces Quarterly Dividend on Common Shares

Business Wire

6 months ago

The RMR Group Announces Quarterly Dividend on Common Shares

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

Business Wire

7 months ago

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

PR Newswire

7 months ago

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

InvestorPlace

7 months ago

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

Institutional owners may ignore Evolv Technologies Holdings, Inc.'s (NASDAQ:EVLV) recent US$65m market cap decline as longer-term profits stay in the green

Simply Wall St.

7 months ago

Institutional owners may ignore Evolv Technologies Holdings, Inc.'s (NASDAQ:EVLV) recent US$65m market cap decline as longer-term profits stay in the green

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

GlobeNewswire

7 months ago

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

7 months ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MESA LABS DECLARES QUARTERLY DIVIDEND

GlobeNewswire

7 months ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Xeris Biopharma Updates Its Outlook for 2023

Business Wire

7 months ago

Xeris Biopharma Updates Its Outlook for 2023

Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares

GuruFocus.com

7 months ago

Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares

Ultra Clean to Participate in 26th Annual Needham Growth Conference

PR Newswire

7 months ago

Ultra Clean to Participate in 26th Annual Needham Growth Conference

Investing in Covenant Logistics Group (NASDAQ:CVLG) three years ago would have delivered you a 196% gain

Simply Wall St.

7 months ago

Investing in Covenant Logistics Group (NASDAQ:CVLG) three years ago would have delivered you a 196% gain

Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

7 months ago

Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

11 High Growth Micro-Cap Stocks to Buy

Insider Monkey

7 months ago

11 High Growth Micro-Cap Stocks to Buy

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

GuruFocus.com

7 months ago

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

ATN International Announces Dividend & Share Buyout Hike

Zacks

7 months ago

ATN International Announces Dividend & Share Buyout Hike

Tandem Diabetes (TNDM) Avails Tandem Source in the United States

Zacks

7 months ago

Tandem Diabetes (TNDM) Avails Tandem Source in the United States

PR Newswire

7 months ago

Aspire North America, LLC Enters Five-Year Exclusive Global Manufacturing and Distribution Agreement with Lifestyle Brand: BrkFst

Does FTAI Infrastructure (FIP) Have an Asymmetric Upside Opportunity?

Insider Monkey

7 months ago

Does FTAI Infrastructure (FIP) Have an Asymmetric Upside Opportunity?

Potential Upside For FTAI Infrastructure Inc. (NASDAQ:FIP) Not Without Risk

Simply Wall St.

8 months ago

Potential Upside For FTAI Infrastructure Inc. (NASDAQ:FIP) Not Without Risk

DISCO Publicly Launches Cecilia, an AI-Powered Platform for Legal Professionals to Transform their Workflows and Accelerate Fact Finding

Business Wire

8 months ago

DISCO Publicly Launches Cecilia, an AI-Powered Platform for Legal Professionals to Transform their Workflows and Accelerate Fact Finding

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds

Insider Monkey

8 months ago

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds

3 Stocks at the Forefront of Personalized Medicine Trend

InvestorPlace

8 months ago

3 Stocks at the Forefront of Personalized Medicine Trend

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript

PR Newswire

8 months ago

Zhihu Inc. Reports Unaudited Third Quarter 2023 Financial Results

Does CS Disco (LAW) Have the Potential to Rally 47.16% as Wall Street Analysts Expect?

Zacks

8 months ago

Does CS Disco (LAW) Have the Potential to Rally 47.16% as Wall Street Analysts Expect?

Do Options Traders Know Something About TETRA Technologies (TTI) Stock We Don't?

Zacks

8 months ago

Do Options Traders Know Something About TETRA Technologies (TTI) Stock We Don't?

President & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stock

Simply Wall St.

8 months ago

President & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stock

PR Newswire

8 months ago

Zhihu Inc. to Report Third Quarter 2023 Financial Results on November 29, 2023

CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript

CryoPort Inc (CYRX) Faces Economic Headwinds but Sees Growth in Key Segments

GuruFocus.com

9 months ago

CryoPort Inc (CYRX) Faces Economic Headwinds but Sees Growth in Key Segments

Associated Press Finance

9 months ago

Lyell Immunopharma: Q3 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023

GlobeNewswire

9 months ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023

Associated Press Finance

9 months ago

ICU Medical: Q3 Earnings Snapshot

Gladstone Land Corporation Earnings Call and Webcast Information

ACCESSWIRE

9 months ago

Gladstone Land Corporation Earnings Call and Webcast Information

ICU Medical Announces Third Quarter 2023 Results

GlobeNewswire

9 months ago

ICU Medical Announces Third Quarter 2023 Results

Share on Social Networks: